---
figid: PMC6468358__cancers-11-00358-g001
figtitle: ADRB2 signaling in prostate cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Equus asinus x Equus caballus
pmcid: PMC6468358
filename: cancers-11-00358-g001.jpg
figlink: /pmc/articles/PMC6468358/figure/cancers-11-00358-f001/
number: F1
caption: ADRB2 signaling in prostate cancer. (A) epinephrine (Epi) and norepinephrine
  (NE) from circulation and secreted locally by sympathetic nerves, neurodifferentiated
  prostate cancer cells and macrophages activate anti-apoptotic signaling in prostate
  cancer cells and stimulate angiogenesis and invasion; (B) Activation of ADRB2 signaling
  (that can be inhibited by propranolol) induces phosphorylation of PKA substrates
  pS133CREB, pS157VASP, p75BAD and increases expression of myeloid cell leukemia 1
  (MCL-1). Dephosphorylations of vasodilator-stimulated phosphoprotein (VASP) and
  cAMP response element binding protein (CREB) reflect inactivation of β-2 adrenergic
  receptor/cAMP-dependent protein kinase (ADRB2/PKA) signaling pathway by propranolol,
  whereas decreased levels of MCL-1 and p75BAD predict whether propranolol will sensitize
  prostate cells to apoptosis.
papertitle: ADRB2-Targeting Therapies for Prostate Cancer.
reftext: George Kulik. Cancers (Basel). 2019 Mar;11(3):358.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7605412
figid_alias: PMC6468358__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC6468358__F1
ndex: 1bc7d48a-df2b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6468358__cancers-11-00358-g001.html
  '@type': Dataset
  description: ADRB2 signaling in prostate cancer. (A) epinephrine (Epi) and norepinephrine
    (NE) from circulation and secreted locally by sympathetic nerves, neurodifferentiated
    prostate cancer cells and macrophages activate anti-apoptotic signaling in prostate
    cancer cells and stimulate angiogenesis and invasion; (B) Activation of ADRB2
    signaling (that can be inhibited by propranolol) induces phosphorylation of PKA
    substrates pS133CREB, pS157VASP, p75BAD and increases expression of myeloid cell
    leukemia 1 (MCL-1). Dephosphorylations of vasodilator-stimulated phosphoprotein
    (VASP) and cAMP response element binding protein (CREB) reflect inactivation of
    β-2 adrenergic receptor/cAMP-dependent protein kinase (ADRB2/PKA) signaling pathway
    by propranolol, whereas decreased levels of MCL-1 and p75BAD predict whether propranolol
    will sensitize prostate cells to apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - epi
  - Tfpi
  - Adrb2
  - Vasp
  - Mcl1
  - Bad
  - Creb1
  - TFPI
  - ADRB2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - VASP
  - MCL1
  - BAD
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - propranolol
  - Epi
  - Ga
---
